These medications work in the brain, in the hypothalamus, to directly reduce appetite and cravings. There are several medications currently on the market that use semaglutide as their main ingredient, including: Presently, Wegovy is the only semaglutide medication FDA-approved for both weight loss and cardiovascular risk reduction
[PUBMED Abstract] Veinalde R, Ozola A, Azarjana K, et al.: Analysis of Latvian familial melanoma patients shows novel variants in the noncoding regions of CDKN2A and that the CDK4 mutation R24H is a founder mutation
In older patients with DM2 and HTN, an observational study correlated empagliflozin administration with decreased endothelial fragility and OS markers, attributable to reduced mitochondrial ROS production in endothelial cells (Mone et al., 2022)
Now, in a pair of clinical trials, researchers investigated whether tirzepatide could improve symptoms of obstructive sleep apnea (OSA), a condition in which individuals may stop breathing while they sleep
This study reported that after 6 months metformin improved knee pain
